May 28, 2025, 23:52

NIH: Innovative Approaches to Studying Cancer Communication in the New Media Environment

This funding opportunity supports research on cancer communication in today’s rapidly evolving digital and media landscape. The focus is on how communication strategies influence cancer-related behaviors, understanding of risks, decision-making, and outcomes across populations. Projects should explore new theories, methods, platforms (like social media, AI tools), and interventions that are culturally sensitive, equity-driven, and scalable.

Eligibility Criteria:

Public and private higher education institutions
For-profit organizations (including small businesses)
Nonprofits (with or without 501(c)(3) status)
Government agencies (local, state, tribal, federal)
Faith-based, community-based, and regional organizations
U.S. Territories and international organizations
HBCUs, HSIs, AANAPISIs, TCCUs, and other minority-serving institutions
No cost sharing required
Multiple applications allowed if distinct

Funding Details:

Funding Instrument: Grant
Activity Code: R01 Research Project Grant
Budget: No cap; must reflect project needs
Project Duration: Up to 5 years
Clinical Trials: Optional

Deadline:

Original Closing Date: May 7, 2026
Expiration Date: May 8, 2026
Applications due by 5:00 PM local time of the applicant organization

Where to Go for Further Information:

FOA Number: PAR-25-092
Full FOA: PAR-25-092 on NIH
Contact: NIH Grants Information – [email protected]
Scientific and grants management contacts listed in Section VII of FOA
Apply via Grants.gov or NIH ASSIST

behavioral research cancer cancer communication cancer disparities communication science digital media health communication health equity NCI NIH OncoDaily Oncology public health R01 grant Social Media

King Albert II’s Brave Battle: A Decade of Fighting Skin Cancer

25 Posts Not To Miss From ESMO GI 2025

Botensilimab and Balstilimab Show Durable Survival in MSS Colorectal Cancer: ESMO GI 2025 Update

Julian McMahon Dies at 56: A Look Back at His Private Cancer Battle and Legendary Acting Career

Vivek Subbiah: It’s Time We Evolve WHO Cancer Classification